Literature DB >> 23219753

Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.

Chang-Han Chen1, Hui-Ching Chuang, Chao-Cheng Huang, Fu-Min Fang, Hsuan-Ying Huang, Hsin-Ting Tsai, Li-Jen Su, Li-Yen Shiu, Steve Leu, Chih-Yen Chien.   

Abstract

The functions of Rap-1A in oral carcinogenesis are largely unexplored. In this study, we examined the expression of Rap-1A at different malignant stages of oral cavity squamous cell carcinoma (OCSCC). Semiquantitative RT-PCR, quantitative RT-PCR, and Western blotting were used to evaluate Rap-1A mRNA and protein expressions, respectively, in paired OCSCC patient specimens. To determine the possible correlation between Rap-1A expression and various clinical characteristics, 256 samples from patients with OCSCC were evaluated by immunohistochemical staining. Strong Rap-1A expression was a significant prognostic marker and predictor of aggressive OCSCC. The overall and disease-specific 5-year survival rates were significantly correlated with strong expression of Rap-1A (P < 0.001). Functionally, overexpressed Rap-1A could promote oral cancer cell migration and invasion by Transwell chambers and wound healing assay. Conversely, the suppression of Rap-1A expression using Rap-1A-mediated siRNA was sufficient to decrease cell motility. Furthermore, our data also illustrated that Aurora-A could not only induce mRNA and protein expressions of Rap-1A for enhancing cancer cell motility but also co-localize and form a complex with Rap-1A in the oral cancer cell line. Finally, immunohistochemical staining, indirect immunofluorescence, and Western blotting analysis of human aggressive OCSCC specimens revealed a significantly positive correlation between Rap-1A and Aurora-A expression. Taken together, our results suggest that the Aurora-A/Rap-1A pathway is associated with survival, tumor progression, and metastasis of OCSCC patients.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219753     DOI: 10.1016/j.ajpath.2012.10.023

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.

Authors:  Danielle J Huk; Amruta Ashtekar; Alexa Magner; Krista La Perle; Lawrence S Kirschner
Journal:  Thyroid       Date:  2018-08-02       Impact factor: 6.568

2.  The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.

Authors:  Ying-En Lee; Hong-Lin He; Tzu-Ju Chen; Sung-Wei Lee; I-Wei Chang; Chung-Hsi Hsing; Chien-Feng Li
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters.

Authors:  Deeksha Pal; Shrawan Kumar Singh; Nandita Kakkar; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2016-09-03

4.  Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.

Authors:  Chang-Han Chen; Hui-Ching Chuang; Yu-Tsai Lin; Fu-Min Fang; Chao-Cheng Huang; Ching-Mei Chen; Hui Lu; Chih-Yen Chien
Journal:  Tumour Biol       Date:  2015-09-04

5.  Expression array analysis of the hepatocyte growth factor invasive program.

Authors:  Fabiola Cecchi; Chih-Jian Lih; Young H Lee; William Walsh; Daniel C Rabe; Paul M Williams; Donald P Bottaro
Journal:  Clin Exp Metastasis       Date:  2015-08-01       Impact factor: 5.150

6.  Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.

Authors:  Chang-Han Chen; Alice Y W Chang; Shau-Hsuan Li; Hsin-Ting Tsai; Li-Yen Shiu; Li-Jen Su; Wen-Lung Wang; Tai-Jen Chiu; Sheng-Dean Luo; Tai-Lin Huang; Chih-Yen Chien
Journal:  Mol Cancer       Date:  2015-04-12       Impact factor: 27.401

7.  Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.

Authors:  Chung-Feng Hwang; Li-Yen Shiu; Li-Jen Su; Wei-Sheng Wang; Shun-Chen Huang; Tai-Jan Chiu; Chao-Cheng Huang; Yen-Yi Zhen; Hsin-Ting Tsai; Fu-Min Fang; Tai-Lin Huang; Chang-Han Chen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

8.  Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.

Authors:  Chih-Yen Chien; Hsin-Ting Tsai; Li-Jen Su; Hui-Ching Chuang; Li-Yen Shiu; Chao-Cheng Huang; Fu-Min Fang; Chun-Chieh Yu; Huei-Ting Su; Chang-Han Chen
Journal:  Oncotarget       Date:  2014-04-30

Review 9.  Aurora-A Kinase as a Promising Therapeutic Target in Cancer.

Authors:  Antonino B D'Assoro; Tufia Haddad; Evanthia Galanis
Journal:  Front Oncol       Date:  2016-01-06       Impact factor: 6.244

10.  MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis.

Authors:  Hailin Li; Guangyu Han; Xing Li; Bowen Li; Bo Wu; Hongyuan Jin; Lingli Wu; Wei Wang
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.